Sensory Profile And Acceptance Of Milk Chocolate Beverage [perfil Sensorial E Aceitação De Bebida Láctea Achocolatada]

The sensory profile of three commercial brands of milk chocolate beverage was obtained using the Quantitative Descriptive Analysis (QDA). Twelve descriptive terms, their definitions, and reference samples were generated by a selected and trained panel. The statistical analysis included the Analysis of Variance (ANOVA), Tukey's Test for means, and Principal Component Analysis (PCA). Brand A showed strong sweetness taste, aroma, and caramel flavor, whereas the predominant characteristics of brand B were the brown color, viscosity, and very intense sandiness. Brand C differed from the others for presenting stronger aroma and milk flavor. An acceptance test was also performed to evaluate the samples thoroughly in terms of the intensity of the ideal sweetness and buying intention. All brands presented high acceptability, and there was no significant difference between them.302391398Almeida, K.E., Bonassi, I.A., Roça, R.O., Características físicas e químicas de bebidas lácteas fermentadas e preparadas com soro de queijo minas frescal (2001) Ciência E Tecnologia De Alimentos, 21 (2), pp. 187-192(2006) Instrução Normativa N° 16, , http://www.agricultura.gov.br, BRASIL. Ministério da Agricultura, Pecuária e Abastecimento, de 23 de agosto de 2005. Regulamento de Identidade e Qualidade de Bebidas Lácteas. Disponível em, Acesso em: junCastro, F.P., Effect of oligofructose incorporation on the properties of fermented probiotic lactic beverages (2009) International Journal of Dairy Technology, 62 (1), pp. 68-74Coker, C.J., Towards the classification of cheese variety and maturity on the basis of statistical analysis of proteolysis data - a review (2005) International Dairy Journal, 15 (2), pp. 631-643Cruz, A.G., Milk Drink Using Whey Butter Cheese (queijo manteiga) and Acerola Juice as a Potential Source of Vitamin C (2009) Food and Bioprocess Technology, 2 (4), pp. 368-373Damasio, M.H., Costell, E., Análisis sensorial descriptivo: Generación de descriptores y selección de catadores (1991) Revista Agroquímica De Tecnología De Alimentos, 31 (2), pp. 165-178Hough, G., Sensory optimization of a powdered chocolate milk formula (1997) Food Quality and Preference, 8 (3), pp. 213-221Kemp, S.E., Application of sensory evaluation in food research (2008) International Journal of Food Science and Technology, 43 (9), pp. 1507-1511Koffi, E., Shewfelt, R., Wicker, L., Storage stability and sensory analysis of UHT-processed whey-banana beverages (2005) Journal of Food Quality, 28 (4), pp. 386-401Kozac, M., Scaman, C.H., Unsupervised classification methods in food science: Discussion and outlook (2008) Journal of The Food Science and Agriculture, 88 (7), pp. 1115-1117Lima, S.M.C.G., Madureira, F.C.P., Penna, A.L.B., Bebidas lácteas - nutritivas e refrescantes (2002) Milkbizz Tecnologia Temático, 1 (3), pp. 4-11Mazzucchelli, R., Guinard, J.X., Comparison of monadic and simultaneous sample presentations mode in a Descriptive analysis of milk chocolate (1999) Journal of Sensory Studies, 14 (3), pp. 245-248Mehinagic, E., Relationship between sensory analysis, penetrometry and visible NR spectroscopy of apples belonging to different cultivars (2003) Food Quality and Preference, 14 (5), pp. 473-484Meilgaard, M., Civille, G.V., Carr, B.T., (1987) Sensory Evaluantion Tecniques, , Boca Raton: CRC PressMoskowitz, H.R., (1983) Product Testing and Sensory Evaluation of Foods: Marketing and R & D Approacher, p. 605. , Westport: Food and Nutrition PressMurray, J.M., Delahunty, C.M., Baxter, I.A., Descriptive sensorial analysis: Past, present and future (2001) Food Research International, 34 (2), pp. 461-471Pifarre, A.M., Acceptability and nutritional quality of a beverage based on orange juice and whey powder, preserved by heat or high-intensity pulsed electric fields (HIPEF) (2006) Archivos Latinoamericanos De Nutricion, 56 (4), pp. 356-360Ritjens, S., (1997) Tendências Mercadológicas Dos Iogurtes E Bebidas Lácteas. In: Leites Fermentados E Bebidas Lácteas: Tecnologia E Mercado, , ITAL: Tecnolat(1989) User's Procedures Guide. Version 6, 2. , SAS, Cary: SAS Institute, IncSimpson, S.J., Piggott, J.R., Williams, S.A.R., Sensorial analysis (1998) International Journal of Food Science and Technology, 33 (1), pp. 7-18Sivieri, K., Oliveira, M.N., Shelf-life evaluation of latic beverages added with fat with mimetics (Litesse and Dairy-Lo) (2002) Ciência E Tecnologia De Alimentos, 22 (1), pp. 24-31Stone, H., Sidel, J.L., Descriptive analysis (1985) Sensory Evaluation Practices, pp. 202-226. , STONE, H.SIDEL, J. L., London: Academic PressThompson, J.L., Preference mapping of commercial chocolates milks (2004) Journal of Food Science, 69 (9), pp. S406-S413Tranjan, B.C., Development of whey goat beverages (2009) International Journal of Dairy Technology, 62 (3), pp. 438-443Yanes, M., Durán, L., Costell, E., Rheological and optical properties of commercial chocolate milk beverages (2002) Journal of Food Engineering, 51 (2), pp. 229-234Zoellner, S.S., Whey beverage containg açaí pulp as food Carrier for probiotic bactéria (2009) Australian Journal of Dairy Technology, 64 (2), pp. 165-16

Efficiency of inactive vaccines against contagious agalactia in Brazil

This paper aims to evaluate the efficiency of three inactive vaccines against contagious agalactia prepared with samples of Mycoplasma agalactiae isolated in Brazil and different adjuvants. Vaccine 1 adsorbed with aluminum hydroxide was administered in 23 goats (Gc1) and 13 sheep (Gov1); vaccine 2 containing Montanide IMS-2215-VG was administered in 22 goats (Gc2) and 12 sheep (Gov2) and vaccine 3, containing Montanide Gel-01 was administered in 22 goats (Gc3) and 12 sheep (Gov3). All animals were negative for Ma at indirect ELISA and received two doses of 2mL each, subcutaneously, within a 21 day interval. Five animals from each species were used as control. Seventy-five days after the booster, four animals from each vaccinated group and two from the control group were challenged with 5mL of Ma culture containing 10(7)cfu/mL, orally and through immersion of the female's udder in lactation. The serological response was analyzed during vaccination days (0 and 21) and at 51, 81, 111, 141 and 171 days after vaccination. The collection and analysis of the challenged animals were conducted at the day of the challenge (D0) and 7, 14, 21, 28, 35, 42, 49 and 56 days after the challenge. The three vaccines induced the production of antibodies, having no significant statistical difference (p<0.05). Animals from groups Gc1, Gc2 and Gov2 developed higher levels of antibodies, with significant statistical difference compared to the other vaccinated group and control group (p<0.05). After the challenge, the animals from the control presented an increase in regional lymph nodes and conjunctivitis, mastitis and arthritis. In four vaccinated animals, discrete conjunctivitis and congestion of the episcleral veins was observed. It is concluded that vaccines 1 and 2 induced levels of protective antibodies in goats and sheep, sufficient for clinical protection of the animals submitted to the experimental infection, indicating its use on the prevention of contagious agalactia

Infecção congênita em cabritos por Mycoplasma agalactiae

This study aimed to report three cases of contagious agalactia (CA) by Mycoplasma agalactiae in goat kids born with polyarthritis. The nanny goats belonging to two different herds presented clinical signs of CA during pregnancy and in parturition they were apparently healthy. The carpal articulations of the three goat kids, the tarsus articulation in one, and thigh-femoral articulation in another showed swelling, pain and impairment of the flexion-extension movements. The articular liquid was collected from two goat kids at birth and revealed a content which varied from transparent to fibrinopurulent, presenting a yellow coloring. The samples were plated on modified Hayflick. The colonies had the appearance of "fried egg" and were confirmed as being M. agalactiae by biochemical tests and 16S rRNA PCR. Blood was collected from three animals soon after birth and submitted to the indirect ELISA test for the determination of the titration of the anti- M. agalactiae antibodies. The results confirmed that the goat kids were infected during pregnancy by M. agalactiae and resulted in the birth of an offspring with clinical signs of CA being immune tolerant

Clinical trials in pediatric ALS: a TRICALS feasibility study

Background: Pediatric investigation plans (PIPs) describe how adult drugs can be studied in children. In 2015, PIPs for Amyotrophic Lateral Sclerosis (ALS) became mandatory for European marketing-authorization of adult treatments, unless a waiver is granted by the European Medicines Agency (EMA). Objective: To assess the feasibility of clinical studies on the effect of therapy in children (&lt;18 years) with ALS in Europe. Methods: The EMA database was searched for submitted PIPs in ALS. A questionnaire was sent to 58 European ALS centers to collect the prevalence of pediatric ALS during the past ten years, the recruitment potential for future pediatric trials, and opinions of ALS experts concerning a waiver for ALS. Results: Four PIPs were identified; two were waived and two are planned for the future. In total, 49 (84.5%) centers responded to the questionnaire. The diagnosis of 44,858 patients with ALS was reported by 46 sites; 39 of the patients had an onset &lt; 18 years (prevalence of 0.008 cases per 100,000 or 0.087% of all diagnosed patients). The estimated recruitment potential (47 sites) was 26 pediatric patients within five years. A majority of ALS experts (75.5%) recommend a waiver should apply for ALS due to the low prevalence of pediatric ALS. Conclusions: ALS with an onset before 18 years is extremely rare and may be a distinct entity from adult ALS. Conducting studies on the effect of disease-modifying therapy in pediatric ALS may involve lengthy recruitment periods, high costs, ethical/legal implications, challenges in trial design and limited information